Literature DB >> 19693765

The peptidylglycine alpha-amidating monooxygenase (PAM): a novel prodrug strategy for amidoximes and N-hydroxyguanidines?

Dennis Schade1, Joscha Kotthaus, Helen Hungeling, Jürke Kotthaus, Bernd Clement.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19693765     DOI： 10.1002/cmdc.200900233

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  2 in total

Review 1.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

2.  A new class of NO-donor pro-drugs triggered by γ-glutamyl transpeptidase with potential for reno-selective vasodilatation.

Authors:  Qingzhi Zhang; Agnieszka Kulczynska; David J Webb; Ian L Megson; Nigel P Botting
Journal:  Chem Commun (Camb)       Date:  2013-02-18       Impact factor: 6.222
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.